Global Levonorgestrel Market Growth 2025-2031

Global Levonorgestrel Market Growth 2025-2031

The global Levonorgestrel market size is predicted to grow from US$ 50.1 million in 2025 to US$ 61.3 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.

Levonorgestrel is a hormonal medication which is used in a number of birth control methods. In pill form, sold under the brand name Plan B among others, it is useful within 120 hours as emergency birth control. It becomes less effective the longer after sex and only works before pregnancy has occurred. It is also combined with an estrogen to make Mixture Products. Within an intrauterine device (IUD), sold as Mirena among others, it is effective for long-term prevention of pregnancy. An implantable form of levonorgestrel is also available in some countries.

Europe is the largest Levonorgestrel market with about 43% market share. Asia-Pacific is follower, accounting for about 29% market share.The key manufacturers are Bayer, Paladin Labs, Foundation Consumer Healthcare, Theramex (Teva), Pfizer, Apotex, HRA Pharma etc. Top 3 companies occupied about 68% market share.

LP Information, Inc. (LPI) ' newest research report, the “Levonorgestrel Industry Forecast” looks at past sales and reviews total world Levonorgestrel sales in 2024, providing a comprehensive analysis by region and market sector of projected Levonorgestrel sales for 2025 through 2031. With Levonorgestrel sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Levonorgestrel industry.

This Insight Report provides a comprehensive analysis of the global Levonorgestrel landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Levonorgestrel portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Levonorgestrel market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Levonorgestrel and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Levonorgestrel.

This report presents a comprehensive overview, market shares, and growth opportunities of Levonorgestrel market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Levonorgestrel Table
Mixture Products
Hormone-releasing IUD

Segmentation by Application:
Hospital
Drug Store
Online Sale

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bayer
Paladin Labs
Foundation Consumer Healthcare
Theramex (Teva)
Pfizer
Apotex
HRA Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Levonorgestrel market?

What factors are driving Levonorgestrel market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Levonorgestrel market opportunities vary by end market size?

How does Levonorgestrel break out by Type, by Application?